# The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer

> **NCT06702683** · — · RECRUITING · sponsor: **Lin Liu** · enrollment: 112 (estimated)

## Conditions studied

- Gastric Carcinoma
- Gastric Neoplasm
- Gastric (cardia, Body) Cancer
- Gastric Cancer Adenocarcinoma Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06702683
- **Lead sponsor:** Lin Liu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-17
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06702683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06702683, "The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06702683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*